ArticleVirology2015

Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.

Erez Pery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.